A Systems Approach to Chronic Disease: A 12-step Clinical Framework for Diagnosis and Management
I started clinical practice in 1992. Over my 30-year career, I have found it important to keep up with the current literature. One case in point is a patient I saw in my clinic in 1996. This was a 50-year-old type
Assessing Mold in Buildings
Assessing Mold in Buildings Assessment Methodology People affected by mold need both a physician experienced in treating mold-related illness and a mold-free environment in which to recover. Indoor mold may be allergenic, infectious, or toxic. The CDC, U.S. EPA, Canada's CHHC,
Misdiagnosed as Anxiety: A Patient Update on Immunoglobulin Deficiency
I want to give an update on a patient I described several months back. This was a patient that came to me who had a history of having bacterial pneumonia requiring hospitalizations almost once a year for the past ten years.
Fatty Liver Disease And Chronic Medication Use
Lately, I have been seeing several of my patients develop fatty liver disease or what has been termed non-alcoholic steatohepatitis or NASH. They have been on medications for multiple years due to underlying chronic illnesses. It seems that recently this problem
Recalcitrant UTIs And DNA Sequences
Recently I assisted a colleague with a patient that was having recurrent UTIs with the same bacteria, E. coli. The concern was that despite appropriate antibiotic therapy the E. coli UTI with Keflex symptoms would improve, but not completely resolve, and
Tirzepatide and Chronic Inflammation
When Cromolyn Sodium Isn't Enough Recently I saw a new patient who had been diagnosed with MCAS, where the diagnosis was confirmed with a positive biopsy of the gastric mucosa. The patient was prescribed cromolyn sodium, but unlike most of my
Sugar Blues
The title of this article is taken from a book written by William Duffy in 1975. Think about it, a book published over fifty years ago talking about the ills of sugar and how the food industry has abused it. Unfortunately,
MCAS Rising
Recently I was evaluating one of my Mast Cell Activating Syndrome (MCAS) patients, who I hadn’t seen in a while, because she was doing well. She has noticed, in addition to her worsening symptoms, that there are more people being diagnosed